Keyword: Teva Pharmaceuticals
Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.
A group of 29 Texas hospitals are suing drug manufacturers, pharmacies and distributors to recover costs for combating the opioid crisis
Elijah Cummings and Bernie Sanders are joining forces again to reopen a 2014 probe into alleged generic drug price fixing.
Blue Cross and Blue Shield of North Carolina has awarded $2 million to five projects tackling the state's opioid epidemic, plus more payer headlines.
The Food and Drug Administration gave the generic version of the Epipen its OK, plus more healthcare headlines.
In-person and electronic communications between more than 30 companies reveal a plot to cause extreme price increases and eliminate competition, the complaint says.
Some drug companies are striking deals that encourage insurers to favor their brand-name products over generics—potentially at the expense of patients.
Federal agencies are taking steps to address the opioid crisis, with HHS announcing millions in grants and the NIH pushing for a long-term plan.